Allianz Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
Other funds holding LJPC
TCM
BC
SAM
VMI
BBA
Allianz Asset Management's LJPC Position: Q1 2019 in Review
Allianz Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2019, closing a stake of 86,009 shares — an estimated $811K sold.
Allianz Asset Management first reported a position in LJPC in Q3 2015 and held it in 14 quarters. The position peaked at $13.2M in Q4 2015. 80 funds tracked by Wall St. Rank hold LJPC as of Q1 2019.
- Allianz Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q1 2019 after selling out during the quarter.
- Allianz Asset Management sold 86,009 La Jolla Pharmaceutical Company shares in Q1 2019, an estimated $811K.
- Allianz Asset Management first reported a position in La Jolla Pharmaceutical Company in Q3 2015 and held it in 14 quarters.
- Allianz Asset Management's La Jolla Pharmaceutical Company position peaked at $13.2M in Q4 2015.
- 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2019.
Based on Allianz Asset Management's 13F filing for Q1 2019, filed 13 May 2019.